ADL

Amdl (ADL)

Amdl,

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:ADL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2018/12/10	22:31	GlobeNewswire Inc.	Edison issues initiation on ADL Bionatur Solutions (BNT)	AMEX:ADL	Amdl,
2018/12/10	22:30	GlobeNewswire Inc.	Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand	AMEX:ADL	Amdl,
2009/09/19	03:32	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ADL	Amdl,
2009/09/18	22:30	PR Newswire (US)	AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US	LSE:ADL
2009/08/20	22:49	PR Newswire (US)	AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc.	LSE:ADL
2009/08/20	06:30	PR Newswire (US)	AMDL Inc. Announces Second Quarter 2009 Financial Results	LSE:ADL
2009/08/20	06:23	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:ADL	Amdl,
2009/08/15	05:10	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	AMEX:ADL	Amdl,
2009/08/15	05:00	PR Newswire (US)	AMDL Inc. Files Notification of Late Filing for Form 10-Q	LSE:ADL
2009/07/22	22:30	PR Newswire (US)	AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009	LSE:ADL
2009/07/08	23:00	PR Newswire (US)	AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer Test	LSE:ADL
2009/07/06	19:04	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (DEFR14A)	AMEX:ADL	Amdl,
2009/07/06	19:04	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	AMEX:ADL	Amdl,
2009/06/26	06:30	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (PRER14A)	AMEX:ADL	Amdl,
2009/06/24	01:08	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(4) (424B4)	AMEX:ADL	Amdl,
2009/06/17	22:30	PR Newswire (US)	AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009	LSE:ADL
2009/06/16	06:33	PR Newswire (US)	AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes	LSE:ADL
2009/06/16	05:22	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ADL	Amdl,
2009/06/12	03:39	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3/A)	AMEX:ADL	Amdl,
2009/05/16	07:10	PR Newswire (US)	AMDL, Inc. Announces First Quarter 2009 Financial Results	LSE:ADL
2009/05/16	05:59	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3)	AMEX:ADL	Amdl,
2009/05/16	05:52	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:ADL	Amdl,
2009/05/14	07:00	PR Newswire (US)	AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer	LSE:ADL
2009/05/08	22:30	PR Newswire (US)	AMDL Inc.'s JJB Plant Receives Production Approval From Chinese State Food and Drug Administration (SFDA)	LSE:ADL
2009/05/08	01:30	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (D)	AMEX:ADL	Amdl,
2009/05/07	04:51	PR Newswire (US)	AMDL Inc. Announces First Closing of Private Placement of 12% Series Two Senior Notes	LSE:ADL
2009/05/07	04:07	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ADL	Amdl,
2009/04/30	22:30	PR Newswire (US)	AMDL, Inc. Signs First Customer Agreement With Precision Diagnostic Laboratory for DR-70 (FDP) Cancer Test	LSE:ADL
2009/04/29	22:30	PR Newswire (US)	Chinese Pharma Market Continues to Grow at a 5-7% Rate in 2009; AMDL Remains on Track to Meet FY09 Financial Targets	LSE:ADL
2009/04/16	06:58	PR Newswire (US)	AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets	LSE:ADL